Pharmacogenomic Analyses Implicate B Cell Developmental Status and MKL1 As Determinants of Sensitivity Toward Anti-CD20 Monoclonal Antibody Therapy
CELLS（2023）
关键词
rituximab (Rituxan (R)),ofatumumab (Arzerra (R),& nbsp,Kesimpta (R)),obinutuzumab (Gazyva (R)),CD20 (MS4A1),MKL1 (MRTFA),TGFB1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要